Loading chat...
IN SB0290
Bill
AI Summary
Senate Bill 290 Summary
-
Classifies materials, compounds, mixtures, or preparations containing ephedrine or pseudoephedrine as Schedule III controlled substances, requiring prescription for dispensing effective July 1, 2015.
-
Repeals the previous law allowing over-the-counter sales of ephedrine and pseudoephedrine products subject to purchase limits, identity verification, and electronic tracking requirements.
-
Repeals related definitions from Indiana Code including "constant video monitoring," "convenience package," "suspicious order," "unusual theft," and retailer-related terms that applied to non-prescription sales.
-
Adds ephedrine and pseudoephedrine to Schedule III stimulants in the controlled substances list alongside other regulated substances.
-
Requires pharmacies and NPLEx retailers that maintained logs before July 1, 2015 to continue maintaining those logs through June 30, 2018 for law enforcement access purposes.
Legislative Description
Ephedrine and pseudoephedrine. Provides that materials, compounds, mixtures, or preparations that contain ephedrine or pseudoephedrine are schedule III controlled substances that may be dispensed only by prescription. Repeals: (1) the law allowing the dispensing of ephedrine and pseudoephedrine without a prescription subject to certain restrictions; and (2) provisions related to that law.
Last Action
First Reading: referred to Committee on Corrections & Criminal Law
1/8/2015